TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Macopharma Nordic AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
3,444
|
4,088
|
5,100 |
Financial expenses |
26
|
64
|
13 |
Earnings before taxes |
5
|
97
|
95 |
EBITDA |
326
|
410
|
259 |
Total assets |
1,804
|
2,231
|
2,241 |
Current assets |
972
|
1,268
|
1,364 |
Current liabilities |
469
|
578
|
823 |
Equity capital |
1,266
|
1,257
|
1,357 |
- share capital |
9
![]() |
9
|
10 |
Employees (average) |
8
|
9
![]() |
9 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
70.2%
|
56.3%
|
60.6% |
Turnover per employee |
430
|
454
|
567 |
Profit as a percentage of turnover |
0.1%
|
2.4%
|
1.9% |
Return on assets (ROA) |
1.7%
|
7.2%
|
4.8% |
Current ratio |
207.2%
|
219.4%
|
165.7% |
Return on equity (ROE) |
0.4%
|
7.7%
|
7.0% |
Change turnover |
-657
|
-598
|
169 |
Change turnover % |
-16%
|
-13%
|
3% |
Chg. No. of employees |
-1
|
0
![]() |
0 |
Chg. No. of employees % |
-11%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.